Healthcare provider profile · identity verified

Brynna Bascetta, APRN

Nurse Practitioner · TORRINGTON, CT · NPI 1932842630

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	197	40
Trazodone Hcl	Trazodone Hcl	178	46
Gabapentin	Gabapentin	173	31
Atorvastatin Calcium	Atorvastatin Calcium	164	33
Furosemide	Furosemide	156	42
Amlodipine Besylate	Amlodipine Besylate	148	36
Tramadol Hcl	Tramadol Hcl	122	38
Metoprolol Succinate	Metoprolol Succinate	104	19
Pantoprazole Sodium	Pantoprazole Sodium	94	23
Mirtazapine	Mirtazapine	89	19
Escitalopram Oxalate	Escitalopram Oxalate	87	23
Donepezil Hcl	Donepezil Hcl	83	17
Potassium Chloride	Potassium Chloride	79	16
Lisinopril	Lisinopril	75	14
Quetiapine Fumarate	Quetiapine Fumarate	73	22
Sertraline Hcl	Sertraline Hcl	72	12
Tamsulosin Hcl	Tamsulosin Hcl	69	15
Eliquis	Apixaban	68	19
Rosuvastatin Calcium	Rosuvastatin Calcium	65	12
Losartan Potassium	Losartan Potassium	64	18
Famotidine	Famotidine	62	16
Memantine Hcl	Memantine Hcl	54	12
Nystatin	Nystatin	54	31
Metformin Hcl	Metformin Hcl	52	suppressed
Carvedilol	Carvedilol	46	suppressed
Duloxetine Hcl	Duloxetine Hcl	46	suppressed
Omeprazole	Omeprazole	45	11
Metoprolol Tartrate	Metoprolol Tartrate	43	13
Simvastatin	Simvastatin	38	suppressed
Prednisone	Prednisone	37	16
Alendronate Sodium	Alendronate Sodium	35	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Finasteride	Finasteride	32	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Lorazepam	Lorazepam	29	13
Risperidone	Risperidone	29	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Olanzapine	Olanzapine	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Allopurinol	Allopurinol	19	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	11
Glipizide	Glipizide	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Ozempic	Semaglutide	14	suppressed
Baclofen	Baclofen	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Valsartan	Valsartan	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Nyamyc	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error